5-MAPB

5-MAPB
Clinical data
Other names	5-(N-Methyl-2-aminopropyl)benzofuran
Routes of; administration	Oral, Insufflated, Rectal
Legal status
Legal status	CA: Schedule I; DE: NpSG (Industrial and scientific use only); UK: Class B; Illegal in China;
Identifiers
	IUPAC name 1-(Benzofuran-5-yl)-N-methylpropan-2-amine;
CAS Number	1354631-77-8;
PubChem CID	102336592;
ChemSpider	32078887;
UNII	XW34GUY2OY;
CompTox Dashboard (EPA)	DTXSID801017189 DTXSID301010102, DTXSID801017189 ;
Chemical and physical data
Formula	C12H15NO
Molar mass	189.25 g/mol (freebase); 225.7 g/mol (HCl salt) g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(NC)CC1=CC(C=CO2)=C2C=C1;
	InChI InChI=1S/C12H15NO/c1-9(13-2)7-10-3-4-12-11(8-10)5-6-14-12/h3-6,8-9,13H,7H2,1-2H3; Key:ZOVRTIPCNFERHY-UHFFFAOYSA-N;

5-MAPB, also known as 5-(N-methyl-2-aminopropyl)benzofuran, is an entactogen and designer drug of the amphetamine family that is similar to MDMA in its structure and effects.^[1]

It has been patented by Tactogen as an entactogen for potential use as a medicine.^[2]

^ "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 June 2013. Retrieved 2013-07-10.
^ Cite error: The named reference WO2021/252538 was invoked but never defined (see the help page).

[ACMD_report-1] "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 June 2013. Retrieved 2013-07-10.

[WO2021/252538-2] Cite error: The named reference WO2021/252538 was invoked but never defined (see the help page).

[1]

[2]